From StockStory: 2025-05-09 15:44:00

Progyny (NASDAQ:PGNY) reported Q1 CY2025 results exceeding revenue expectations, with sales up 16.5% to $324 million. Non-GAAP profit of $0.48 per share beat estimates by 7.7%. Revenue guidance for the year was raised to $1.21 billion, with adjusted EPS guidance at $1.59. Management highlighted increased client adoption and higher member engagement, citing shifting demographics and new service modules driving growth. The company continues to monitor macroeconomic factors but remains optimistic about stable demand. Analysts are watching for progress on new service modules, client acquisitions, and margin management. Progyny trades at a forward P/E ratio of 14.2x.

Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but new trade policies may impact growth in 2025. Despite investor uncertainty, StockStory’s Top 5 Growth Stocks list offers high-quality picks for long-term growth. Past selections like Nvidia and Exlservice have delivered significant returns, making this curated list a valuable resource for investors seeking market-beating stocks. Check out StockStory’s list to find your next big winner in today’s market climate.



Read more at StockStory: Product Expansion, Member Growth, and Guidance Raised